Pau Hung To cuts ADVB stake to 0% via $480K share payoff
Advanced Biomed Inc. (ADVB) is the subject of an amended Schedule 13G/A filed by shareholder Pau Hung To.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Advanced Biomed Inc. (ADVB) is the subject of an amended Schedule 13G/A filed by shareholder Pau Hung To. The reporting person now reports 0 shares of Advanced Biomed common stock beneficially owned, representing 0% of the class. This change reflects transfers of 100,000 shares to Lu Yi and 76,225 shares to Zhao Jie on July 27, 2026, in each case in satisfaction of indebtedness of the reporting person with an aggregate principal amount of $480,000. Following these transfers, the filer reports no voting or dispositive power over any Advanced Biomed shares.
Key Figures
Key Terms
beneficially owned financial
dispositive power financial
percent of class financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What percentage of Advanced Biomed Inc. (ADVB) does Pau Hung To currently beneficially own?
What class of securities of ADVB is covered in this Schedule 13G/A filing?
AI-generated analysis. How Rhea-AI works. Not financial advice.